Annual accounts receivable:
$158.55M-$2.27M(-1.41%)Summary
- As of today (May 21, 2025), PTCT annual accounts receivable is $158.55 million, with the most recent change of -$2.27 million (-1.41%) on December 31, 2024.
- During the last 3 years, PTCT annual accounts receivable has risen by +$48.10 million (+43.55%).
- PTCT annual accounts receivable is now -1.41% below its all-time high of $160.82 million, reached on December 31, 2023.
Performance
PTCT Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$210.50M+$51.94M(+32.76%)Summary
- As of today (May 21, 2025), PTCT quarterly accounts receivable is $210.50 million, with the most recent change of +$51.94 million (+32.76%) on March 1, 2025.
- Over the past year, PTCT quarterly accounts receivable has increased by +$12.84 million (+6.49%).
- PTCT quarterly accounts receivable is now at all-time high.
Performance
PTCT Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
PTCT Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | +6.5% |
| 3 y3 years | +43.5% | +49.0% |
| 5 y5 years | +185.5% | +300.0% |
PTCT Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.4% | +43.5% | at high | +69.1% |
| 5 y | 5-year | -1.4% | +185.5% | at high | +300.0% |
| alltime | all time | -1.4% | >+9999.0% | at high | >+9999.0% |
PTCT Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $210.50M(+32.8%) |
| Dec 2024 | $158.55M(-1.4%) | $158.55M(-20.7%) |
| Sep 2024 | - | $199.98M(+6.9%) |
| Jun 2024 | - | $187.15M(-5.3%) |
| Mar 2024 | - | $197.66M(+22.9%) |
| Dec 2023 | $160.82M(+3.3%) | $160.82M(-3.0%) |
| Sep 2023 | - | $165.72M(-6.6%) |
| Jun 2023 | - | $177.50M(-12.1%) |
| Mar 2023 | - | $201.87M(+29.7%) |
| Dec 2022 | $155.61M(+40.9%) | $155.61M(+25.0%) |
| Sep 2022 | - | $124.46M(-8.4%) |
| Jun 2022 | - | $135.94M(-3.8%) |
| Mar 2022 | - | $141.29M(+27.9%) |
| Dec 2021 | $110.45M(+58.0%) | $110.45M(+14.3%) |
| Sep 2021 | - | $96.64M(+22.6%) |
| Jun 2021 | - | $78.80M(-16.3%) |
| Mar 2021 | - | $94.12M(+34.6%) |
| Dec 2020 | $69.93M(+25.9%) | $69.93M(+23.1%) |
| Sep 2020 | - | $56.79M(+5.9%) |
| Jun 2020 | - | $53.64M(+1.9%) |
| Mar 2020 | - | $52.62M(-5.2%) |
| Dec 2019 | $55.54M | $55.54M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $60.38M(-21.7%) |
| Jun 2019 | - | $77.10M(+66.4%) |
| Mar 2019 | - | $46.35M(-31.7%) |
| Dec 2018 | $67.91M(+68.1%) | $67.91M(+60.9%) |
| Sep 2018 | - | $42.20M(-28.9%) |
| Jun 2018 | - | $59.38M(+30.2%) |
| Mar 2018 | - | $45.61M(+12.9%) |
| Dec 2017 | $40.39M(+62.0%) | $40.39M(+4.3%) |
| Sep 2017 | - | $38.74M(+14.7%) |
| Jun 2017 | - | $33.77M(+5.0%) |
| Mar 2017 | - | $32.17M(+29.1%) |
| Dec 2016 | $24.93M(+124.7%) | $24.93M(-9.0%) |
| Sep 2016 | - | $27.41M(+38.7%) |
| Jun 2016 | - | $19.77M(-12.6%) |
| Mar 2016 | - | $22.62M(+103.9%) |
| Dec 2015 | $11.09M(+149.6%) | $11.09M(+38.4%) |
| Sep 2015 | - | $8.02M(+56.7%) |
| Jun 2015 | - | $5.11M(+60.9%) |
| Mar 2015 | - | $3.18M(-28.5%) |
| Dec 2014 | $4.45M(+364.0%) | $4.45M(+243.0%) |
| Sep 2014 | - | $1.30M(+35.3%) |
| Dec 2013 | $958.00K | $958.00K |
FAQ
- What is PTC Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for PTC Therapeutics?
- What is PTC Therapeutics annual accounts receivable year-on-year change?
- What is PTC Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for PTC Therapeutics?
- What is PTC Therapeutics quarterly accounts receivable year-on-year change?
What is PTC Therapeutics annual accounts receivable?
The current annual accounts receivable of PTCT is $158.55M
What is the all time high annual accounts receivable for PTC Therapeutics?
PTC Therapeutics all-time high annual accounts receivable is $160.82M
What is PTC Therapeutics annual accounts receivable year-on-year change?
Over the past year, PTCT annual accounts receivable has changed by -$2.27M (-1.41%)
What is PTC Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of PTCT is $210.50M
What is the all time high quarterly accounts receivable for PTC Therapeutics?
PTC Therapeutics all-time high quarterly accounts receivable is $210.50M
What is PTC Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, PTCT quarterly accounts receivable has changed by +$12.84M (+6.49%)